Paul Schimmel

Paul Schimmel

Fondatore presso
Reactive Biosciences, Inc.

Patrimonio netto: 1 M $ in data 30/06/2026

85 anni
Health Technology
Commercial Services
Finance

Profilo

Paul R.
Schimmel
was the founder of Reactive Biosciences, Inc. (founded 2021), Alkermes, Inc. (founded 1987), Metabolon, Inc. (founded 2000), Abide Therapeutics, Inc. (founded 2011; Director), aTyr Pharma, Inc. (founded 2005; Independent Director), Repligen Corp.
(founded 1981; Co-Chairman), Alnylam Pharmaceuticals, Inc. (founded 2002; Independent Director), Momenta Pharmaceuticals, Inc. (founded 2001; Director), and Sirtris Pharmaceuticals, Inc. (founded 2004; Director).
Dr. Schimmel is also the founder of Cubist Pharmaceuticals LLC..
Current positions include Director at KinDex Pharmaceuticals, Inc. and Tevard Biosciences, Inc., Professor at The Scripps Research Institute (since 1997) and Skaggs Institute For Chemical Biology, Member of the National Academy of Sciences, National Academy of Medicine (United States), National Academy of Inventors, American Academy of Arts & Sciences, American Philosophical Society, and National Academy of Medicine, Advisor at Longwood Fund Management LLC, and Venture Partner at CHP Management, Inc. Former positions include Chairman of the Biological Chemistry Division at the American Chemical Society, Director at Momenta, Inc., Independent Director at Tocagen, Inc. (2015–2020), Director at Avicena Group, Inc., Vividion Therapeutics, Inc., and Alkermes Plc, Professor at Massachusetts Institute of Technology, and Member of the Scientific Advisory Board at Illumina, Inc. Education includes a doctorate from Cornell University, a doctorate from Massachusetts Institute of Technology (1966), and undergraduate studies at Ohio Wesleyan University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
27/05/2026 2.201.056 ( 2,24% ) 1 M $ 30/06/2026

Posizioni attive di Paul Schimmel

SocietàPosizioneInizio
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Investitore di Private Equity -
Corporate Officer/Principal -
Corporate Officer/Principal -
Direttore/Membro del Consiglio -
Fondatore 01/01/2021
Corporate Officer/Principal -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -

Precedenti posizioni note di Paul Schimmel

SocietàPosizioneFine
░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Vedi nel dettaglio l'esperienza di Paul Schimmel

Formazione di Paul Schimmel

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

75

Relazioni di 1° grado

32

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private32

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Commercial Services

Finance

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Distribution Services

National Academy of Medicine

Finance

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Skaggs Institute For Chemical Biology

  1. Mercati
  2. Insiders
  3. Paul Schimmel